0
Skip to Content
CTIC Capital
Home
Team
Events
News
Contact
CTIC Capital
Home
Team
Events
News
Contact
Home
Team
Events
News
Contact
Tianjun Song 3/17/23 Tianjun Song 3/17/23

YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ

Read More
Tianjun Song 3/10/23 Tianjun Song 3/10/23

Biocytogen Announces RenLite® Licensing Agreement with Janssen

Read More
Tianjun Song 3/3/23 Tianjun Song 3/3/23

Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376

Read More
Tianjun Song 2/24/23 Tianjun Song 2/24/23

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23

Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed

Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)

Read More
Tianjun Song 2/20/23 Tianjun Song 2/20/23

Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

Read More
Tianjun Song 11/8/22 Tianjun Song 11/8/22

Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion

Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22

Ascletis announce signing license and supply agreement of ritonavir for COVID-19 drug PAXLOVID™ in mainland China With Pfizer

Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22

XtalPi Announces Research Collaboration with Janssen

Read More
Tianjun Song 10/28/22 Tianjun Song 10/28/22

JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies

Read More
Ning Feng 10/26/22 Ning Feng 10/26/22

HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers

Read More
Ning Feng 10/24/22 Ning Feng 10/24/22

C4XD and HitGen to collaborate in inflammation hit identification project

Read More
Ning Feng 10/11/22 Ning Feng 10/11/22

IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder

Read More
Ning Feng 9/29/22 Ning Feng 9/29/22

Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc

Read More
Ning Feng 9/27/22 Ning Feng 9/27/22

Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK® (tisotumab vedotin-tftv)

Read More
Ning Feng 9/21/22 Ning Feng 9/21/22

Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China

Read More
Ning Feng 9/14/22 Ning Feng 9/14/22

METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi

Read More
Guest User 8/21/22 Guest User 8/21/22

Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical Group

Read More
Guest User 8/21/22 Guest User 8/21/22

Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China

Read More
Newer Posts
Older Posts

CTIC CAPITAL

Palo Alto I New York I Chicago I Hong Kong I Suzhou I Munich